The novel approach of this peptide represents a major advance in the handling of diabetes mellitus type 2. Unlike existing medications, tirzepatide targets multiple pathways – GLP-1 and GIP – leading to improved https://tirzepatidepeptide150783.designertoblog.com/73490112/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment